Predictors of invasive fungal infection in pediatric allogeneic hematopoietic SCT recipients

Bone Marrow Transplantation

Volumn 49, Issue 1, 2014, Pages 95-101

  Hol, J A ^a   Wolfs, T F W ^a   Bierings, M B ^a   Lindemans, C A ^a   Versluys, A B J ^a   Wildt De, A ^a   Gerhardt, C E ^a   Boelens, J J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Invasive fungal infection; Pediatric allo SCT; Predictors; Prophylaxis; Risk stratification

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; CASPOFUNGIN; STEROID; VORICONAZOLE;

ACUTE GRAFT VERSUS HOST DISEASE; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIFUNGAL RESISTANCE; ARTICLE; ASPERGILLOSIS; ASPERGILLUS; CANDIDA; CHILD; DRUG MEGADOSE; DRUG USE; EXOPHIALA; FEMALE; FUNGAL DETECTION; FUSARIUM; GRAFT RECIPIENT; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYCOSIS; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; ZYGOMYCETES;

ADOLESCENT; ADULT; AMPHOTERICIN B; ANTIFUNGAL AGENTS; ASPERGILLOSIS; CANDIDIASIS; CHILD; CHILD, PRESCHOOL; ECHINOCANDINS; FEMALE; FUSARIOSIS; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; LOGISTIC MODELS; MALE; MYCOSES; NEUTROPHILS; PROSPECTIVE STUDIES; PYRIMIDINES; RETROSPECTIVE STUDIES; RISK; TREATMENT OUTCOME; TRIAZOLES; YOUNG ADULT;

EID: 84891884498     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2013.136     Document Type: Article

References (24)

1. Dvorak CC, Steinbach WJ, Brown JMY, Agarwal R. Risks and outcomes of invasive fungal infections in pediatric patients undergoing allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2005; 36: 621-629.
2. Kobayashi R, Kaneda M, Sato T, Suzuki D, Ichikawa M, Ariga T. Evaluation of risk factors for invasive fungal infection after allogeneic stem cell transplantation in pediatric patients. J Pediatr Hematol Oncol 2007; 29: 786-791.
3. Kobayashi R, Kaneda M, Sato T, Ichikawa M, Suzuki D, Ariga T. The clinical feature of invasive fungal infection in pediatric patients with hematologic and malignant diseases: a 10-year analysis at a single institution at Japan. J Pediatr Hematol Oncol 2008; 30: 886-890.
4. Hovi L, Saarinen-Pihkala UM, Vettenranta K, Saxen H. Invasive fungal infections in pediatric bone marrow transplant recipients: single center experience of 10 years. Bone Marrow Transplant 2000; 26: 999-1004.
5. Benjamin Jr DK, Miller WC, Bayliff S, Martel L, Alexander KA, Martin PL. Infections diagnosed in the first year after pediatric stem cell transplantation. Pediatr Infect Dis J 2002; 21: 227-234.
6. Crassard N, Hadden H, Pondarre C, Hadden R, Galambrun C, Piens MA et al. Invasive aspergillosis and allogeneic hematopoietic stem cell transplantation in children: a 15-year experience. Transpl Infect Dis 2008; 10: 177-183.
7. Mikulska M, Raiola AM, Bruno B, Furfaro E, Van Lint MT, Bregante S et al. Risk factors for invasive aspergillosis and related mortality in recipients of allogeneic SCT from alternative donors: an analysis of 306 patients. Bone Marrow Transplant 2009; 44: 361-370.
8. Srinivasan A, Wang C, Srivastava DK, Burnette K, Shenep JL, Leung W et al. Timeline, epidemiology, and risk factors for bacterial, fungal, and viral infections in children and adolescents after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2012, pii S1083-8791: 00334-00335.
9. Marr KA, Carter RA, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002; 34: 909-917.
10. Barnes PD, Risks Marr KA. Diagnosis and outcomes of invasive fungal infections in haematopoietic stem cell transplant recipients. Br J Haematol 2007; 139: 519-531.
11. Castagnola E, Faraci M, Moroni C, Bandettini R, Granata C, Caruso S et al. Invasive mycoses in children receiving hemopoietic SCT. Bone Marrow Transplant 2008; 41: S107-S111.
12. Kontoyiannis DP, Marr KA, Park BJ, Alexander BD, Anaissie EJ, Walsh TJ et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant- Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis 201015 50: 1091-1100.
13. Kontoyiannis DP. Antifungal prophylaxis in hematopoietic stem cell transplant recipients: the unfinished tale of imperfect success. Bone Marrow Transplant 2011; 46: 165-173.
14. Rogers TR, Slavin MA, Donnelly JP. Antifungal prophylaxis during treatment for haematological malignancies: are we there yet? Br J Haematol 2011; 153: 681-697.
15. Pauw de BE. What are fungal infections? Mediterr J Hematol Infect Dis 2011; 3: e2011001.
16. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295-304.
17. Gratwohl A. The EBMT risk score. Bone Marrow Transplant 2012; 47: 749-756.
18. Pauw DeB, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T et al. Revised definitions of invasive fungal disease from European organisation for research and treatment of cancer/invasive fungal infections cooperative Group and the national institute of allergy and infectious diseases mycoses study Group (EORTC/MSG) concensus Group. Clin Infect Dis 2008; 46: 1813-1821.
19. Blyth CC, Hale K, Palasanthiran P, O'Brien T, Bennett MH. Antifungal therapy in infants and children with proven, probable or suspected invasive fungal infections. Cochrane Database Syst Rev 2010; 17: CD006343.
20. Snelders E, van der Lee HA, Kuijpers J, Rijs AJ, Varga J, Samson RA et al. Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism. PLoS Med 2008; 5: e219.
21. Bartelink IH, Wolfs T, Martine J, de Waal M, Egberts TC, Ververs TT et al. Immune reconstitution kinetics as an early predictor for mortality using various hematopoietic stem cell sources in children. Biol Blood Marrow Transplant 2012, 22. pii S1083-8791: 00426-0.
22. Ram R, Gafter-Gvili A, Yeshurun M, Paul M, Raanani P, Shpilberg O. Prophylaxis regimens for GVHD: systematic review and meta-analysis. Bone Marrow Transplant 2009; 43: 643-653.
23. Ferrara JL, Levine JE, Reddy P, Holler E. Graft-versus-host disease. Lancet 2009; 373: 1550-1561.
24. Rocha V, Locatelli F. Searching for alternative hematopoietic stem cell donors for pediatric patients. Bone Marrow Transplant 2008; 41: 207-214.